Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAL: Maraviroc + ART in Late Diagnosed HIV-1
NCT01348308Phase 3Completed
- Sponsor
- ANRS
- Start
- Sep 2011
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Started Sep 2011; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01348308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01348308.